US Federal Senate Bill SB1716

US Federal 2025-2026 Regular Session

• Introduced: 5/12/25
• Refer: 5/12/25

Caption

Vision Lab Choice Act of 2025

Summary

The Vision Lab Choice Act of 2025 would amend the Public Health Service Act to change how vision-care benefits are administered under group health plans and individual or group health insurance coverage that includes vision services, including limited-scope vision plans. The bill sets rules for agreements between vision plans and doctors of optometry, limiting the initial term of such agreements to no more than two years and allowing renewals only with the optometrist’s prior acceptance, also in terms of up to two years each. It further prohibits plans and issuers from directly or indirectly restricting an optometrist’s choice of laboratories, or the source or supplier of services and materials provided to enrollees. The bill also creates an enforcement framework under which the Secretary of Health and Human Services must annually notify states of their authority to enforce the new vision-plan requirements and ask whether they will do so. If a state declines or does not respond, the federal government would treat that state as not substantially enforcing the provisions for purposes of federal enforcement under the Public Health Service Act. A conforming amendment clarifies that these new requirements are carved out from an existing preemption-related provision. In practical terms, the bill would affect health insurance issuers, employers sponsoring group health plans, and limited-scope vision benefit plans by imposing federal standards on contract duration and provider autonomy in vision care networks. It would also affect doctors of optometry by giving them greater flexibility in contracting and in selecting labs and suppliers, while potentially limiting insurer control over those business arrangements. The general sentiment reflected by the bill’s introduction is supportive of greater provider choice and reduced insurer restrictions in the vision-care market. The bill was introduced by Senators Cramer, Murphy, and Mullin and referred to the Senate HELP Committee, with no recorded votes or committee debate available in the provided materials. Because there is no transcript or vote history, there is no evidence of formal opposition in the record supplied, but the structure of the bill suggests likely tension over federal versus state authority and over insurer/network management practices. The main point of contention is the balance between federal standards and state regulation. The bill expressly preserves exclusive application of state law where it directly governs health insurance issuers and vision benefit plans and where state law conflicts with the federal amendments, which may raise questions about preemption and the scope of state enforcement. Another likely area of debate is whether the restrictions on insurer contracting and sourcing requirements improve consumer access and provider independence or instead interfere with plan cost control and network design.

Impact

The bill would add a new section to title XXVII of the Public Health Service Act governing vision-care coverage, creating federal requirements for limited-scope vision plans and related insurance coverage. It would limit the duration of optometrist agreements, bar restrictions on optometrists’ choice of laboratories and suppliers, and establish a state-notification and federal fallback enforcement process. It also includes a conforming amendment to existing federal health insurance provisions and a clause preserving state law where it directly governs vision benefit plans and conflicts with the federal changes.

Sentiment

The available context suggests a generally favorable or pro-provider sentiment, with the bill framed as improving choice and flexibility in vision coverage. It was introduced by bipartisan sponsors and referred to committee without recorded opposition, votes, or hearing testimony in the provided materials. Because there is no transcript, the record does not show formal support or criticism, but the bill’s design indicates an intent to address perceived insurer restrictions in vision-plan contracting.

Contention

The most notable contention is likely between optometrists and vision insurers over control of contracts, laboratories, and suppliers. Supporters would view the bill as protecting provider autonomy and consumer choice, while opponents may argue it limits insurer ability to manage costs and network quality. A second point of contention is federalism: the bill gives states a role in enforcement but also creates a federal backstop and addresses preemption, which could prompt debate over whether state or federal rules should control vision benefit plans.